Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DARE

Dare Bioscience Inc

Apr 28 • 04:00PM ET

2.19

-0.05 -2.23 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: MDGL VKTX EPIX IGC AIM TVRD SEDG VTGN ADMA BPMC

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.33	Insider Own	8.32%	Shs Outstand	14.50M	Perf Week	-7.20%
Market Cap	31.88M	Forward P/E	-	EPS next Y	-0.59	Insider Trans	0.00%	Shs Float	13.35M	Perf Month	41.29%
Enterprise Value	15.22M	PEG	-	EPS next Q	-0.30	Inst Own	8.43%	Short Float	1.27%	Perf Quarter	11.17%
Income	-13.40M	P/S	30.95	EPS this Y	-0.83%	Inst Trans	1.70%	Short Ratio	0.48	Perf Half Y	3.79%
Sales	1.03M	P/B	11.17	EPS next Y	51.24%	ROA	-	Short Interest	0.17M	Perf YTD	13.47%
Book/sh	0.20	P/C	1.29	EPS next 5Y	56.32%	ROE	-	52W High	9.19 -76.17%	Perf Year	-24.22%
Cash/sh	1.70	P/FCF	-	EPS past 3/5Y	35.13% 35.73%	ROIC	-152.46%	52W Low	1.27 72.44%	Perf 3Y	-81.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-53.12% -	Gross Margin	-137.55%	Volatility	10.41% 13.10%	Perf 5Y	-88.07%
Dividend TTM	-	EV/Sales	14.78	EPS Y/Y TTM	-209.84%	Oper. Margin	-1315.51%	ATR (14)	0.25	Perf 10Y	-99.49%
Dividend Ex-Date	-	Quick Ratio	1.14	Sales Y/Y TTM	-	Profit Margin	-1300.66%	RSI (14)	54.96	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.14	EPS Q/Q	81.96%	SMA20	4.99%	Beta	1.07	Target Price	8.50
Payout	-	Debt/Eq	2.83	Sales Q/Q	2355.39%	SMA50	24.37%	Rel Volume	0.48	Prev Close	2.24
Employees	24	LT Debt/Eq	2.10	Earnings	Mar 26 AMC	SMA200	10.36%	Avg Volume	353.02K	Price	2.19
IPO	Apr 10, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	106.82% 36.22%	Trades		Volume	170,925	Change	-2.23%

Mar-26-26 04:01PM	Dare Bioscience Reports Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire) +7.86%
Mar-25-26 09:22AM	Dare Bioscience Inc (DARE) Q4 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-23-26 08:00AM	On National Viagra Day, Women Finally Claim Their Turn: (GlobeNewswire)
Mar-20-26 08:00AM	Dare Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026 (GlobeNewswire)
Mar-16-26 08:00AM	Dare Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth (GlobeNewswire)
08:00AM	Loading…
Mar-12-26 08:00AM	Dare Bioscience Participates in Virtual Investor "What This Means" Segment (GlobeNewswire)
Mar-09-26 08:25AM	Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-02-26 08:20AM	uniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -5.29%
Feb-23-26 08:00AM	Dare Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer (GlobeNewswire)
Feb-11-26 08:00AM	Telehealth Now Available for DARE to PLAY Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women (GlobeNewswire)
Dec-10-25 08:00AM	DARE to PLAY Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility (GlobeNewswire) +6.99%
Dec-01-25 08:00AM	Dare Bioscience Announces Return of Rights to Ovaprene; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization (GlobeNewswire) -9.24%
Nov-24-25 08:00AM	Dare Bioscience Receives $3.6 Million in Additional Grant Funding (GlobeNewswire) +6.55%
Nov-14-25 12:02AM	Dare Bioscience Inc (DARE) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... (GuruFocus.com)
Nov-13-25 05:10PM	Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Loading…
04:01PM	Dare Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-12-25 05:30PM	Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:37AM	Earnings To Watch: Dare Bioscience Inc (DARE) Reports Q3 2025 Result (GuruFocus.com)
Nov-11-25 08:00AM	Dare Bioscience Highlights Commercial Launch Readiness for DARE to PLAY Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women's Sexual Health (GlobeNewswire) +6.59%
Nov-10-25 08:25AM	Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-06-25 06:25PM	Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Dare Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 (GlobeNewswire)
Nov-05-25 05:10PM	Arcellx, Inc. (ACLX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-04-25 08:55AM	AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -5.73%
Nov-03-25 08:00AM	Dare Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment (GlobeNewswire)
Oct-06-25 08:00AM	Dare Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders (GlobeNewswire)
Sep-24-25 08:00AM	Dare Bioscience to Receive up to $499,000 to Support Preeclampsia Research (GlobeNewswire)
Aug-15-25 03:23AM	Dare Bioscience Inc (DARE) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... (GuruFocus.com) +6.28%
Aug-14-25 05:15PM	Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
04:01PM	Loading…
04:01PM	Dare Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-13-25 08:15AM	Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-12-25 05:15PM	Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-07-25 08:15AM	C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -9.73%
08:00AM	Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025 (GlobeNewswire)
08:00AM	Dare Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025 (GlobeNewswire)
Aug-06-25 08:15AM	Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.83%
Jul-29-25 08:00AM	Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil Cream (GlobeNewswire)
08:00AM	Dare Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil Cream (GlobeNewswire)
Jul-21-25 01:47PM	UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY Difference - The Sildenafil Cream That Raises the Bar (GlobeNewswire) +6.35%
01:47PM	UPDATE - Dare Bioscience to Host August 6 Webinar: The DARE to PLAY Difference - The Sildenafil Cream That Raises the Bar (GlobeNewswire)
08:00AM	Daré Bioscience to Host August 6 Webinar: The DARE to PLAY Difference - The Sildenafil Cream That Raises the Bar (GlobeNewswire)
08:00AM	Dare Bioscience to Host August 6 Webinar: The DARE to PLAY Difference - The Sildenafil Cream That Raises the Bar (GlobeNewswire)
Jul-14-25 08:00AM	Positive Interim Phase 3 Results Highlight Potential of Ovaprene, Novel Hormone-Free Contraceptive (GlobeNewswire) +22.86%
Jul-11-25 08:00AM	Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders (GlobeNewswire) +5.23%
08:00AM	Dare Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders (GlobeNewswire)
Jun-12-25 05:00PM	Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
05:00PM	Dare Bioscience Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-06-25 09:40AM	Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jun-04-25 08:00AM	Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Darés DARE to PLAY Sildenafil Cream (GlobeNewswire)
08:00AM	Dare Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Dare's DARE to PLAY Sildenafil Cream (GlobeNewswire)
May-14-25 12:53PM	Q1 2025 Dare Bioscience Inc Earnings Call (Thomson Reuters StreetEvents)
03:14AM	Dare Bioscience Inc (DARE) Q1 2025 Earnings Call Highlights: Strategic Expansions and Cost ... (GuruFocus.com)
May-13-25 05:10PM	Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update (GlobeNewswire)
04:01PM	Dare Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update (GlobeNewswire)
May-12-25 05:25PM	Acadia Healthcare (ACHC) Beats Q1 Earnings Estimates (Zacks)
May-08-25 06:10PM	Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-06-25 08:00AM	Daré Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025 (GlobeNewswire)
08:00AM	Dare Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025 (GlobeNewswire)
Apr-23-25 08:00AM	Dare Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women's Health Innovation (GlobeNewswire)
08:00AM	Dar Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women's Health Innovation (GlobeNewswire)
Apr-08-25 12:24AM	XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist (Seeking Alpha)
Apr-07-25 08:00AM	Dar Bioscience to Present at the Jones Healthcare and Technology Innovation Conference on Expanded Business Strategy Including Action to Make its Proprietary Sildenafil Cream Formulation Available via Prescription This Year (GlobeNewswire)
Apr-01-25 09:56AM	Q4 2024 Dare Bioscience Inc Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Dare Bioscience Inc (DARE) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial ... (GuruFocus.com)
Mar-31-25 10:14PM	Dare Bioscience, Inc. (DARE) Q4 2024 Earnings Call Transcript (Seeking Alpha)
05:15PM	Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Dare Bioscience Reports Full Year 2024 Financial Results and Provides Company Update (GlobeNewswire)
04:01PM	Dar Bioscience Reports Full Year 2024 Financial Results and Provides Company Update (GlobeNewswire)
Mar-24-25 08:00AM	Dare Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025 (GlobeNewswire)
08:00AM	Dar Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025 (GlobeNewswire)
Feb-20-25 08:00AM	Dar Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant (GlobeNewswire)
Feb-06-25 08:00AM	Dare Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development (GlobeNewswire)
08:00AM	Dar Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development (GlobeNewswire)
Jan-09-25 08:00AM	Dare Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
08:00AM	Dar Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-16-24 08:00AM	Dare Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD) (GlobeNewswire)
08:00AM	Dar Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD) (GlobeNewswire)
Dec-10-24 08:00AM	Dar Bioscience Announces Publication in Sexual Medicine of Positive Findings from Demographic, Behavioral and Medication Use Subgroup Analyses in the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% (GlobeNewswire)
Dec-04-24 08:00AM	Dare Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1 (GlobeNewswire)
08:00AM	Dar Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1 (GlobeNewswire)
Nov-15-24 01:54PM	Q3 2024 Dare Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) -9.96%
02:19AM	Dare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ... (GuruFocus.com)
Nov-14-24 05:10PM	Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -7.04%
04:01PM	Dare Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
04:01PM	Dar Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
Nov-13-24 08:00AM	Dare Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene Pivotal Study Clinical Trial Sites (GlobeNewswire) -13.04%
08:00AM	Dar Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene Pivotal Study Clinical Trial Sites (GlobeNewswire)
Nov-07-24 12:00PM	Dare Bioscience (DARE) Upgraded to Buy: Here's What You Should Know (Zacks)
08:00AM	Dare Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024 (GlobeNewswire)
08:00AM	Dar Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024 (GlobeNewswire)
Oct-23-24 12:30PM	Dare Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health (GlobeNewswire)
12:30PM	Dar Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health (GlobeNewswire)
Oct-21-24 08:05AM	Dare Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC (GlobeNewswire)
08:05AM	Dar Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC (GlobeNewswire)
Aug-26-24 08:00AM	Dar Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% (GlobeNewswire)
Aug-13-24 08:00AM	Dare Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% (GlobeNewswire) +20.00%
08:00AM	Dar Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% (GlobeNewswire)
Aug-12-24 05:15PM	Dare Bioscience, Inc. (DARE) Q2 Earnings Top Estimates (Zacks)

Dare Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DARE

Dare Bioscience Inc

Upgrade your Finviz experience